Vanguard Asset Management’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
Other funds holding ABUS
Vanguard Asset Management's ABUS Position: Q3 2026 in Review
Vanguard Asset Management increased its Arbutus Biopharma (ABUS) stake by 34% in Q3 2026, buying an estimated $148K and bringing the position to 120,351 shares worth $575K. The position accounts for ﹤0.01% of the portfolio, ranked #2118.
Vanguard Asset Management first reported a position in ABUS in Q1 2026 and has held it in 3 quarters since. 216 funds tracked by Wall St. Rank hold ABUS as of Q3 2026.
- Vanguard Asset Management held 120,351 shares of Arbutus Biopharma worth $575K as of Q3 2026.
- Vanguard Asset Management bought 30,769 Arbutus Biopharma shares in Q3 2026, an estimated $148K.
- Arbutus Biopharma made up ﹤0.01% of Vanguard Asset Management's portfolio in Q3 2026, its #2118 holding.
- Vanguard Asset Management first reported a position in Arbutus Biopharma in Q1 2026 and has held it in 3 quarters since.
- 216 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q3 2026.
Based on Vanguard Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.